தன்னாட்சி பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தன்னாட்சி பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தன்னாட்சி பரிசோதனை Today - Breaking & Trending Today

DARPA to Develop Hand-Held Disease Detection Device

DARPA to Develop Hand-Held Disease Detection Device
nationaldefensemagazine.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationaldefensemagazine.org Daily Mail and Mail on Sunday newspapers.

John Julias , Rachel Fezzie , Meredith Roaten , Defense Advanced Research Projects Agency , Develop Hand Held Disease Detection , Gene Editing Technologies , Autonomous Diagnostics , Enable Prevention , ஜான் ஜூலியாஸ் , கீந் திருத்துதல் தொழில்நுட்பங்கள் , தன்னாட்சி பரிசோதனை ,

DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™

October 2, 2013 at 9:00 AM EDT
Research to focus on antibody production for immune defense
CAMBRIDGE, Mass., October 2, 2013 Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the
in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats.
Messenger RNA therapeutics™ can be designed to tap directly into the body’s natural processes to produce antibodies without exposing people to a weakened or inactivated virus or pathogen, as is the case with the vaccine approaches currently being tested. As a result, Moderna’s messenger RNA therapeutics™ p ....

United Kingdom , United States , Defense Advanced Research Projects Agency , Moderna Therapeutics , Autonomous Diagnostics , Enable Prevention , Prophylactic Options , Contagious Threats , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , மாடர்னா சிகிச்சை , தன்னாட்சி பரிசோதனை ,

Is DARPA implantable microchip to detect COVID-19 the mark of the beast?

Is DARPA implantable microchip to detect COVID-19 the mark of the beast?
(Photo credit: Shutterstock.com / Gorodenkoff)
The Defense Advanced Research Projects Agency, commonly referred to as DARPA, was established during the Cold War more than 60 years ago. For 60 years, DARPA has maintained and advanced the mission of making “pivotal investments in breakthrough technologies for national security.”
Many are familiar with their human and animal-like robots, but recently, they have taken on another mission that involves being prepared for future pandemics like COVID 19. Recently, the organization has invested more in this area. DARPA’s Pandemic Prevention Platform (P3) program, which started in 2017, looks at finding, describing, producing, testing, and the delivery of effectual DNA and RNA encoded medical technologies to fight infectious disease. According to its website, the technological aspects of this research were developed by the organization und ....

Bill Whitaker , Matt Hepburn , Department Of Defense Do , Technologies Office , Defense Advanced Research Projects Agency , White House National Security Staff , Cold War , Prevention Platform , Autonomous Diagnostics , Enable Prevention , Biological Technologies , Medical Preparedness , White House National Security , ர சி து வைட்டேக்கர் , மேட் ஹெப்பர்ன் , துறை ஆஃப் பாதுகாப்பு செய் , தொழில்நுட்பங்கள் அலுவலகம் , வெள்ளை வீடு தேசிய பாதுகாப்பு ஊழியர்கள் , குளிர் போர் , ப்ரெவெந்ஶந் நடைமேடை , தன்னாட்சி பரிசோதனை , உயிரியல் தொழில்நுட்பங்கள் , மருத்துவ ப்ரிப்யாரெட்நெஸ் , வெள்ளை வீடு தேசிய பாதுகாப்பு ,

Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation

TMCnet News
Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation
[December 28, 2020]
Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation
MIAMI, Dec. 28, 2020 /PRNewswire/
Â Heru, Inc., a 3 Seasons Capital, LLC portfolio medical technology company, has received Class 1 listing with the U.S. Food and Drug Administration (FDA) registration for developing a next-generation, artificial intelligence (AI)-driven platform for vision diagnostics and augmentation. Heru is the first diagnostic application for visual field exams. ....

United States , University Of Miami Hospital , Fred Drasner , Eduardoc Alfonso , Ken Frydman , Heru Inc , Cosmeceutical Technologies , Prnewswire Heru Inc , Drug Administration , Bascom Palmer Eye Institute , Seasons Health Care , Computer Augmented Vision Lab , Seasons Capital , Portfolio Medical Technology Company , Medical Technology Company , Receives Class , Artificial Intelligence , Driven Platform , Vision Diagnostics , Miami Hospital , Bascom Palmer Eye , Mohamed Abou Shousha , Associate Professor , Clinical Ophthalmology , Computer Engineering , Biomedical Engineering ,